| 870 ANTI-MICROBIOTA SYSTEMIC IGG DEPLETES PROTECTIVE BUTYRATEPRODUCING COMMENSALS IN IBD AND LONG PRECEDES CROHN'S DISEASE ONSET J Gifford, A Lo, E Ivleva, N Gooder, D Shiramizu, MS Riddle, JS Magee, ... Gastroenterology 166 (5), S-201, 2024 | | 2024 |
| The Role of Enteric Infection and the Microbiome in Human Health and Disease MS Riddle Clinical Understanding of the Human Gut Microbiome, 25-32, 2024 | | 2024 |
| Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data J Dreyfus, S Munnangi, C Bengtsson, B Correia, R Figueiredo, JH Stark, ... Vaccine 42 (5), 1094-1107, 2024 | | 2024 |
| Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with … RL Gutiérrez, CK Porter, C Harro, K Talaat, MS Riddle, B DeNearing, ... Microorganisms 12 (2), 288, 2024 | 1 | 2024 |
| Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention KS Blake, DJ Schwartz, S Paruthiyil, B Wang, J Ning, SD Isidean, ... MBio 15 (1), e02790-23, 2024 | 1 | 2024 |
| Reassessing potential economic value and health impact of effective Shigella vaccines WP Hausdorff, JD Anderson IV, AL Bourgeois, A Clifford, JA Fleming, ... Bulletin of the World Health Organization 102 (1), 65, 2024 | 2 | 2024 |
| 1631. Background Incidence Rates of Health Outcomes Relevant to Vaccine Monitoring in Lyme Disease Endemic and Non-endemic US Regions using Administrative Claims Data J Dreyfus, S Munnangi, M DeKoven, C Bengtsson, B Correia, ... Open Forum Infectious Diseases 10 (Suppl 2), 2023 | | 2023 |
| Vaccine value profile for norovirus G Armah, BA Lopman, J Vinjé, M O'Ryan, CF Lanata, M Groome, J Ovitt, ... Vaccine 41, S134-S152, 2023 | 5 | 2023 |
| Serum antibody levels to SARS-CoV-2 receptor-binding domain (RBD) in convalescent patients and vaccinated individuals of northern Nevada D Hau, KJ Pflughoeft, MA Gates-Hollingsworth, S Kaur, HJ Hill, ... Plos one 18 (11), e0288713, 2023 | | 2023 |
| A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic Escherichia coli CFA/I Fimbrial Tip Adhesin … RL Gutiérrez, MS Riddle, CK Porter, M Maciel Jr, ST Poole, RM Laird, ... Microorganisms 11 (11), 2689, 2023 | 1 | 2023 |
| Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries BK Giersing, R Isbrucker, DC Kaslow, M Cavaleri, N Baylor, D Maiga, ... The Lancet Global Health 11 (11), e1819-e1826, 2023 | 3 | 2023 |
| GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy … C Duplessis, KA Clarkson, KR Turbyfill, AN Alcala, R Gutierrez, MS Riddle, ... Vaccine 41 (42), 6261-6271, 2023 | 2 | 2023 |
| S633 Diagnosis and Management Utilization Amongst Veterans With IBS by IBS-Subtype and Provider Specialty JN Becker, PL Claassen, CKL Cravalho, G Cecchini, P Cay, A Rai, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S680 Gender and Differences in Diagnosis and Management of Veterans With IBS: A Retrospective Cohort Study Within a VA Health Care System PL Claassen, JN Becker, CKL Cravalho, G Cecchini, P Cay, A Rai, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| Preclinical serological signatures are associated with complicated Crohn’s disease phenotype at diagnosis F Petralia, J Torres, RC Ungaro, C Porter, T Sato, S Telesco, RS Strauss, ... Clinical Gastroenterology and Hepatology 21 (11), 2928-2937. e12, 2023 | 9 | 2023 |
| Use of a smartphone-based medication adherence platform to improve outcomes in uncontrolled type 2 diabetes among veterans: prospective case-crossover study A Rai, M Riddle, R Mishra, N Nguyen, K Valine, M Fenney JMIR diabetes 8, e44297, 2023 | 2 | 2023 |
| Advances on the forefront of travellers’ diarrhoea MS Riddle, CD Ericsson, R Steffen Journal of Travel Medicine 30 (6), taad123, 2023 | 2 | 2023 |
| Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low-and middle-income countries: Report of an expert convening MS Riddle, AL Bourgeois, A Clifford, S Jeon, BK Giersing, M Jit, ... Vaccine 41 (16), 2634-2644, 2023 | 7 | 2023 |
| Anti-integrin αvβ6 autoantibodies are a novel biomarker that antedate ulcerative colitis AE Livanos, A Dunn, J Fischer, RC Ungaro, W Turpin, SH Lee, S Rui, ... Gastroenterology 164 (4), 619-629, 2023 | 26 | 2023 |
| DOP16 Anti-integrin αvβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomes A Livanos, A Dunn, J Fischer, RC Ungaro, W Turpin, SH Lee, S Rui, ... Journal of Crohn's and Colitis 17 (Supplement_1), i79-i80, 2023 | | 2023 |
Patrick ConnorHead, Military Enteric Diseases Group, RCDM, UK在 doctors.org.uk 的电子邮件经过验证
